Patents Assigned to SYMBIOX, INC.
  • Patent number: 12616718
    Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: May 5, 2026
    Assignee: SYMBIOX, INC.
    Inventor: Jose-Tomas Egana-Erazo
  • Patent number: 12600938
    Abstract: Methods of storage and preservation of photosynthetically active cells and photosynthetic biomaterials are provided herein. Contemplated methods comprise storing the cells and biomaterials at a refrigeration temperature, optionally without light. The stored cells and biomaterials may be placed in a nitrogen containing medium under illumination before use. The chlorophyll content, oxygen consumption rate, oxygen production rate and/or morphology may be substantially preserved throughout the storage and awakening process.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: April 14, 2026
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomás Egaña-Erazo, Rocio Corrales-Orovio
  • Patent number: 12594299
    Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.
    Type: Grant
    Filed: August 19, 2022
    Date of Patent: April 7, 2026
    Assignee: SYMBIOX, INC.
    Inventor: Jose-Tomas Egana-Erazo
  • Patent number: 12564604
    Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.
    Type: Grant
    Filed: August 19, 2022
    Date of Patent: March 3, 2026
    Assignee: SYMBIOX, INC.
    Inventor: Jose-Tomas Egana-Erazo
  • Patent number: 12419907
    Abstract: Systems and methods for developing and applying photosynthetic cellular substances to a human or animal for medical, therapeutic or cosmetic uses are provided. Photosynthetic cells, such as algal cells, can be used in these substances to provide the ability to continuously generate oxygen when exposed to a light source or other oxygen-generating trigger. The substances can be developed as a standalone liquid, gel or cream, or embedded within a bandage, mesh, scaffold or other structure with a light source to promote oxygen production. The substances can be applied topically for medical, therapeutic or cosmetic treatments, or injected internally for generation of oxygen within one or more parts of the body.
    Type: Grant
    Filed: May 19, 2023
    Date of Patent: September 23, 2025
    Assignee: SYMBIOX, INC.
    Inventor: Jose-Tomas Egana-Erazo
  • Patent number: 12390501
    Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.
    Type: Grant
    Filed: April 25, 2023
    Date of Patent: August 19, 2025
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
  • Patent number: 11666616
    Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: June 6, 2023
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
  • Patent number: 11207362
    Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 28, 2021
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
  • Patent number: 9849150
    Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: December 26, 2017
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomas Egana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen
  • Patent number: 9144589
    Abstract: The present invention is concerned with a photosynthetic scaffold that delivers oxygen and its uses for tissue engineering and the treatment of ischemia.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: September 29, 2015
    Assignee: SYMBIOX, INC.
    Inventors: Jose-Tomas Eagana-Erazo, Hans-Gunther Machens, Ursula Hopfner, Joerg Nickelsen